granted
on 02 Apr 2024
Last Applicant/ Owned by
15th Floor 3 Columbus Circle
New York
NY
10019
Serial Number
88900009 filed on 04th May 2020
Registration Number
N/A
Correspondent Address
Devon E. White
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical product development services; Pharmaceutical product evaluation services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of pharmaceuticals for the treatment of cancer and oncological conditions; Research and development of vaccines and medicines; Technical rRead More
Pharmaceutical product development services; Pharmaceutical product evaluation services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of pharmaceuticals for the treatment of cancer and oncological conditions; Research and development of vaccines and medicines; Technical research in the field of pharmaceutical studies; Development of computer platform technology, namely, development of cancer immunotherapy software platforms for manufacturing therapeutics; Consulting services for others in the field of design, planning, and implementation of clinical trials; Information technology platform as Service (PaaS) featuring computer software platforms for cancer diagnosis and analysis of cancer symptoms and cancer treatment, in the medical field; Electronic data storage; Providing a bioinformatics platform as a service (PAAS) featuring computer software platforms for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Scientific research and analysis for medical purposes in the field of cancer, oncology and clinical trials
Pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; Pharmaceuticals, namely, drug delivery agents in the form of compounds that facilitate delivery of injectable pharmaceutical preparations and in the form of subcutaneous compounds that provide controlled release, and in the form of injectable pharmaceuticals, powders, tablets, capsules, pills, caplets, liquid drops, sachets, spray, ointment, cream, gel, lotion, patch, inhaler, granule, film, suspension, infusion and suppository, capsules, and tablets of peptide nucleic acids for the treatment of cancer and oncological conditions; Oncological preparations, namely, pharmaceutical preparations for the detection, prevention, and treatment of cancer; Pharmaceutical and medicinal preparations for the treatment of cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, bacterial infection, peripheral blood stem cell mobilization, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, viral infections, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells; Stem cells for medical purposes; Synthetic peptides for the treatment of cancer and oncological conditions; Biological tissue cultures for medical purposes; Therapeutic products, namely, antibodies, proteins and peptide therapeutics for treating cancer and oncological conditions; Vaccine preparations; Medical assays for testing of body fluids
No 88900009
No Service Mark
No 024726.124
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 03rd Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 02th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
| 02th Apr 2024 | SOU EXTENSION 1 FILED |
| 02th Apr 2024 | SOU EXTENSION 1 GRANTED |
| 03rd Oct 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 08th Aug 2023 | PUBLISHED FOR OPPOSITION |
| 08th Aug 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Jul 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 06th Jul 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 28th Mar 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
